vimarsana.com

Latest Breaking News On - Krishna yeshwant - Page 1 : vimarsana.com

Two GV partners on biotech s reset and building their next drug startups

BioPharma

Krishna yeshwantDan lynchDavid sontagDavid schenkeinAnthony philippakisEben robbinsFlatiron healthPlayer healthBroad instituteOne medicalEditas medicinePrime medicineBiopharma diveNorth star

3 Once-in-a-Lifetime Gene Editing Stocks with Surge Potential

Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example.

Krishna yeshwantModerna incNational organization for rare disordersNational organizationEli lillyVerve therapeuticsGlobalx genomics

$18M Bet On Verve Therapeutics? Check Out These 3 Stocks Insiders Are Buying - Big Lots (NYSE:BIG), Heartland Express (NASDAQ:HTLD)

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

United statesChristopherj mccormickJulie durrKrishna yeshwantVerve therapeutics incHeartland express incBig lotsBig lots incBig lots doesHeartland expressHeartland express doesVerve therapeuticsVerve therapeutics does

The Most Important VCs in Boston, According to Other Investors

The greater Boston area claims a number of savvy, if under-the-radar, investors as residents. We asked VCs about the ones to know.

United kingdomHarvard universityUnited statesNew yorkMclean hospitalCity ofEben robbinsLiz christoMaren bannonKleida martiroRohan malhotraVivjan myrtoJamie goldsteinKula bioLily lymanMillie liu

Nimbus Therapeutics raises $210 million in fundraising round

The Boston-based biotech will work on new "small molecule" drugs to combat cancer and other ailments.

United statesUnited kingdomJeb keiperBill gatesKrishna yeshwantEli lillySv health investorsAtlas ventureGilead sciencesBain capital life sciencesTakeda pharmaceuticalSeaport districtLightstone venturesPfizer ventures

vimarsana © 2020. All Rights Reserved.